<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ900518-0071</DOCNO><DOCID>900518-0071.</DOCID><HL>   Business Brief -- Medco Research Inc.:   Accord With Oppenheimer   On Finding Buyer Is Ended</HL><DATE>05/18/90</DATE><SO>WALL STREET JOURNAL (J), NO PAGE CITATION</SO><CO>   MEDR</CO><IN>TENDER OFFERS, MERGERS, ACQUISITIONS (TNM)</IN><LP>   Medco Research Inc. said it and Oppenheimer andamp; Co., itsinvestment banker, mutually agreed to end their agreementunder which Oppenheimer was exploring the possibility ofselling the Los Angeles company earlier than planned.   The agreement was set to terminate in August, said Medco,a drug company that develops treatments and diagnoses ofcardiovascular diseases. Although Oppenheimer contacted a&quot;significant number&quot; of pharmaceuticals concerns aboutacquiring the company, Medco said, none of them elected tofollow through. The company retained Oppenheimer in November.</LP><TEXT>   Medco said it didn't plan to hire another investmentbanker immediately. The company added, however, that it maylater review various &quot;strategic alternatives&quot; available toit.</TEXT></DOC>